Merit Medical(US:MMSI)2025-07-30 21:00Q2 2025 Financial Performance (GAAP) - Revenue increased by 132% to $3825 million in Q2 2025 compared to $3380 million in Q2 2024[8] - Net income decreased by 88% to $326 million in Q2 2025 from $357 million in Q2 2024[8] - Earnings per share decreased by 116% to $054 in Q2 2025 compared to $061 in Q2 2024[8] Q2 2025 Financial Performance (Non-GAAP) - Revenue increased by 67% to $3606 million in Q2 2025 compared to $3380 million in Q2 2024[9] - Net income increased by 133% to $610 million in Q2 2025 from $538 million in Q2 2024[9] - Earnings per share increased by 98% to $101 in Q2 2025 compared to $092 in Q2 2024[9] Revenue Breakdown (Q2 2025) - US revenue increased by 167% to $227082 thousand in Q2 2025[11] - APAC revenue decreased by 04% to $66566 thousand in Q2 2025[11] - EMEA revenue increased by 165% to $72615 thousand in Q2 2025[11] Fiscal Year 2025 Financial Guidance - Sales Net are projected to be between $1495 billion and $1507 billion, representing a 10%-11% year-over-year change[14] - Non-GAAP earnings per share are expected to be between $352 and $372, representing a 2%-8% year-over-year change[14]